1-4 of 4
Jean Luc Pellegrin
Close
Sort by
Journal Articles

Risk and Response Adapted Conventionnal Treatment Strategy In AL Amyloidosis: The French Experience Since 2007

Arnaud Jaccard, Frank Bridoux, Margaret Macro, MD, Jean Luc Pellegrin, Olivier Tournilhac, MD, PhD, Murielle Roussel, MD, Bruno Moulin, Xavier Leleu, MD, PhD, Denis Caillot, MD, David Lavergne, Jean Paul Fermand, MD
Journal: Blood
Blood (2013) 122 (21): 3175.
https://doi.org/10.1182/blood.V122.21.3175.3175
Published: 2013
Journal Articles

Intrinsic Impairment of Platelet Production in Persistent/Chronic ITP

Etienne Riviere, Jean-François Viallard, MD, PhD, Juliana Vieira Dias, PhD, Anne Cecile Pons, Thierry Couffinhal, MD, PhD, Jean-Luc Pellegrin, MD, PhD, Chloe James, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 624.
https://doi.org/10.1182/blood.V120.21.624.624
Published: 2012
Journal Articles

Platelet-associated CD154 in immune thrombocytopenic purpura

Brief Report
Anne Solanilla, Jean-Max Pasquet, Jean-François Viallard, Cécile Contin, Christophe Grosset, Julie Déchanet-Merville, Maryse Dupouy, Marc Landry, Francis Belloc, Paquita Nurden, Patrick Blanco, Jean-François Moreau, Jean-Luc Pellegrin, Alan T. Nurden, Jean Ripoche
Journal: Blood
Blood (2005) 105 (1): 215–218.
https://doi.org/10.1182/blood-2003-07-2367
Published: 2005
Journal Articles

Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

Brief Report
Jean-François Viallard, Anne Solanilla, Bruno Gauthier, Cécile Contin, Julie Déchanet, Christophe Grosset, Jean-François Moreau, Vincent Praloran, Paquita Nurden, Jean-Luc Pellegrin, Alan T. Nurden, Jean Ripoche
Journal: Blood
Blood (2002) 99 (7): 2612–2614.
https://doi.org/10.1182/blood.V99.7.2612
Published: 2002